These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 23374366)

  • 1. Sensitive detection of 3'-hydroxy-stanozolol glucuronide by liquid chromatography-tandem mass spectrometry.
    Tudela E; Deventer K; Van Eenoo P
    J Chromatogr A; 2013 May; 1292():195-200. PubMed ID: 23374366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanding analytical possibilities concerning the detection of stanozolol misuse by means of high resolution/high accuracy mass spectrometric detection of stanozolol glucuronides in human sports drug testing.
    Schänzer W; Guddat S; Thomas A; Opfermann G; Geyer H; Thevis M
    Drug Test Anal; 2013; 5(11-12):810-8. PubMed ID: 23873860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of stanozolol O- and N-sulfate metabolites and their evaluation as additional markers in doping control.
    Balcells G; Matabosch X; Ventura R
    Drug Test Anal; 2017 Jul; 9(7):1001-1010. PubMed ID: 27714936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel dummy molecularly imprinted polymer for simultaneous solid-phase extraction of stanozolol metabolites from urine.
    Farag YG; Hanafi RS; Hammam MA
    Anal Bioanal Chem; 2024 Jun; 416(14):3335-3347. PubMed ID: 38661944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel HPLC-MRM strategy to discover unknown and long-term metabolites of stanozolol for expanding analytical possibilities in doping-control.
    Wang Z; Zhou X; Liu X; Dong Y; Zhang J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jan; 1040():250-259. PubMed ID: 27842983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stanozolol-N-glucuronide metabolites in human urine samples as suitable targets in terms of routine anti-doping analysis.
    Göschl L; Gmeiner G; Gärtner P; Stadler G; Enev V; Thevis M; Schänzer W; Guddat S; Forsdahl G
    Drug Test Anal; 2021 Sep; 13(9):1668-1677. PubMed ID: 34089570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a simple online-SPE method coupled to high-resolution mass spectrometry for the analysis of stanozolol-N-glucuronides in urine samples.
    Göschl L; Gmeiner G; Enev V; Kratena N; Gärtner P; Forsdahl G
    Drug Test Anal; 2020 Aug; 12(8):1031-1040. PubMed ID: 32302468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection and structural investigation of metabolites of stanozolol in human urine by liquid chromatography tandem mass spectrometry.
    Pozo OJ; Van Eenoo P; Deventer K; Lootens L; Grimalt S; Sancho JV; Hernández F; Meuleman P; Leroux-Roels G; Delbeke FT
    Steroids; 2009 Oct; 74(10-11):837-52. PubMed ID: 19464304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for anabolic steroids in doping analysis by liquid chromatography/electrospray ion trap mass spectrometry.
    Deventer K; Eenoo PV; Delbeke FT
    Biomed Chromatogr; 2006 May; 20(5):429-33. PubMed ID: 16177960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complementing the characterization of in vivo generated N-glucuronic acid conjugates of stanozolol by collision cross section computation and analysis.
    Thevis M; Dib J; Thomas A; Höppner S; Lagojda A; Kuehne D; Sander M; Opfermann G; Schänzer W
    Drug Test Anal; 2015; 7(11-12):1050-6. PubMed ID: 26514814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct quantitation of endogenous steroid sulfates in human urine by liquid chromatography-electrospray tandem mass spectrometry.
    Esquivel A; Alechaga É; Monfort N; Ventura R
    Drug Test Anal; 2018 Nov; 10(11-12):1734-1743. PubMed ID: 29797686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Automated and sensitive determination of four anabolic androgenic steroids in urine by online turbulent flow solid-phase extraction coupled with liquid chromatography-tandem mass spectrometry: a novel approach for clinical monitoring and doping control.
    Guo F; Shao J; Liu Q; Shi JB; Jiang GB
    Talanta; 2014 Jul; 125():432-8. PubMed ID: 24840468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of anabolic androgenic steroids as sulfate conjugates using high performance liquid chromatography coupled to tandem mass spectrometry.
    Rzeppa S; Heinrich G; Hemmersbach P
    Drug Test Anal; 2015; 7(11-12):1030-9. PubMed ID: 26472592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-isobutyloxycarbonylation for improved detection of 3'-hydroxystanozolol and its 17-epimer in doping control.
    Choi MH; Chung BC
    Analyst; 2001 Mar; 126(3):306-9. PubMed ID: 11284331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary detection of conjugated and unconjugated anabolic steroids by dilute-and-shoot liquid chromatography-high resolution mass spectrometry.
    Tudela E; Deventer K; Geldof L; Van Eenoo P
    Drug Test Anal; 2015 Feb; 7(2):95-108. PubMed ID: 24753397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analytical challenges in doping control: Comprehensive two-dimensional gas chromatography with time of flight mass spectrometry, a promising option.
    Silva AI; Pereira HM; Casilli A; Conceição FC; Aquino Neto FR
    J Chromatogr A; 2009 Apr; 1216(14):2913-22. PubMed ID: 19013575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-throughput liquid chromatography tandem mass spectrometry assay as initial testing procedure for analysis of total urinary fraction.
    Sobolevsky T; Ahrens B
    Drug Test Anal; 2021 Feb; 13(2):283-298. PubMed ID: 32852861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gas chromatographic-mass spectrometric identification of main metabolites of stanozolol in cattle after oral and subcutaneous administration.
    Ferchaud V; Le Bizec B; Montrade MP; Maume D; Monteau F; André F
    J Chromatogr B Biomed Sci Appl; 1997 Aug; 695(2):269-77. PubMed ID: 9300863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Confirmatory analysis of residues of stanozolol and its major metabolite in bovine urine by liquid chromatography-tandem mass spectrometry.
    Draisci R; Palleschi L; Marchiafava C; Ferretti E; Delli Quadri F
    J Chromatogr A; 2001 Aug; 926(1):69-77. PubMed ID: 11554420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of stanozolol: chemical synthesis and identification of a major canine urinary metabolite by liquid chromatography-electrospray ionisation ion trap mass spectrometry.
    Stewart RT; McKinney AR; Kerwick CM; Young EB; Vadasz A; Cade IA; Willis AC; McLeod MD
    J Steroid Biochem Mol Biol; 2009 Nov; 117(4-5):152-8. PubMed ID: 19748583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.